Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche 1 Year Total Returns (Daily): 11.91% for Nov. 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 14, 2024 | 11.91% |
November 13, 2024 | 16.67% |
November 12, 2024 | 20.00% |
November 11, 2024 | 20.29% |
November 08, 2024 | 19.14% |
November 07, 2024 | 20.23% |
November 06, 2024 | 20.30% |
November 05, 2024 | 20.64% |
November 04, 2024 | 22.29% |
November 01, 2024 | 25.10% |
October 31, 2024 | 23.00% |
October 30, 2024 | 23.18% |
October 29, 2024 | 24.46% |
October 28, 2024 | 25.39% |
October 25, 2024 | 27.41% |
October 24, 2024 | 25.67% |
October 23, 2024 | 26.60% |
October 22, 2024 | 22.55% |
October 21, 2024 | 21.82% |
October 18, 2024 | 17.82% |
October 17, 2024 | 16.05% |
October 16, 2024 | 14.17% |
October 15, 2024 | 15.10% |
October 14, 2024 | 14.18% |
October 11, 2024 | 17.11% |
Date | Value |
---|---|
October 10, 2024 | 14.13% |
October 09, 2024 | 18.27% |
October 08, 2024 | 17.63% |
October 07, 2024 | 16.52% |
October 04, 2024 | 16.48% |
October 03, 2024 | 19.94% |
October 02, 2024 | 21.06% |
October 01, 2024 | 18.36% |
September 30, 2024 | 20.57% |
September 27, 2024 | 23.56% |
September 26, 2024 | 23.02% |
September 25, 2024 | 18.07% |
September 24, 2024 | 20.68% |
September 23, 2024 | 17.98% |
September 20, 2024 | 14.00% |
September 19, 2024 | 16.95% |
September 18, 2024 | 13.84% |
September 17, 2024 | 13.86% |
September 16, 2024 | 12.27% |
September 13, 2024 | 12.47% |
September 12, 2024 | 11.22% |
September 11, 2024 | 15.57% |
September 10, 2024 | 13.73% |
September 09, 2024 | 12.71% |
September 06, 2024 | 19.23% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-28.70%
Minimum
Mar 27 2023
42.00%
Maximum
Dec 27 2019
4.88%
Average
5.00%
Median
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 19.93% |
CRISPR Therapeutics AG | -15.28% |
Addex Therapeutics Ltd | 36.67% |
NLS Pharmaceutics Ltd | -84.10% |
Molecular Partners AG | 19.32% |